MDS Analytical Technologies Application Note Challenge
MDS Analytical Technologies is dedicated to helping advance your research. Therefore, we have initiated the Application Note Challenge to enable life science researchers to easily share applications with others who are using MDS Analytical Technologies hardware and software research tools.
Researchers who submit an abstract that is accepted will qualify for the incentives listed below. Only one incentive type (Instrument, Software, or Reagent) will be awarded:
| Area of research |
Product Families |
Instrument Incentive |
Software Incentive |
Reagents Incentive |
Contact |
| Cellular Imaging |
ImageXpressULTRA™, ImageXpressMICRO™, ImageXpress™ 5000A, IsoCyte™, Discovery 1®, AcuityXpress™ software, MetaXpress® software |
$10,000 credit towards the purchase of an ImageXpress or IsoCyte system; or $2,500 credit towards the purchase of an ImageXpressMICRO accessory; or |
Single license of AcuityXpress software; or 50% discount towards the upgrade of existing MetaXpress software license with additional Application Modules or Upgrade to MetaXpress 3.0 software |
|
jayne.hesley @moldev.com |
| Laser Capture Microdissection (LCM) |
ArcturusXT™, PixCell®, Veritas™, HistoGene®, PicoPure®, RiboAmp®, Paradise®, Turbo Labeling™ |
$10,000 credit towards the purchase of an Arcturus® LCM instrument; or |
|
$1,000 credit towards the purchase of Arcturus reagents or consumables |
steve.blakely @moldev.com |
| Microarray Systems |
Axon GenePix® microarray scanners, GenePix® Pro software, Acuity® software |
|
Single license of GenePix Pro software |
|
sandra.prietz @moldev.com |
| Research Imaging |
MetaMorph® Software |
1 paragraph tool tip = software maintenance agreement. 3-5 paragraph method description plus images = free version upgrade or application module. These items will be published in the MetaMatters newsletter. |
mary.david @moldev.com |
| Ion Channel Drug Discovery |
PatchXpress® 7000A, DataXpress® software |
|
Two concurrent-seat licenses of DataXpress Software; or |
Three boxes of SealChip16™ Electrodes |
jan.dolzer @moldev.com |
If you have an exciting application for a specific MDS Analytical Technologies product that is not listed, please check this page again soon, as we are updating this list regularly, or contact us at info@moldev.com with "Application Note Challenge" referenced in the subject line.
Guidelines for Submission and Acceptance
Interested parties are required to first submit a non-confidential one-page document containing an abstract or summary of their application note and supporting data ("Submission"). Abstracts should be submitted electronically, attached as a Word document, to the specific contact person listed in the table above with "Application Note Challenge" referenced in the subject line.
MDS Analytical Technologies ("MDS AT") will review the Submission within 2-4 weeks of receipt. Upon acceptance of the Submission, applicants will have thirty (30) days to submit a completed application note. MDS AT will notify applicants of acceptance of their completed application note within ten (10) days following receipt by MDS AT. If the application note is rejected, the applicant will be notified, indicating the reason(s) for rejection. The applicant will then have fifteen (15) days to correct and resubmit the application note to MDS AT.
The MDS AT product credit will be awarded after MDS AT acceptance of the completed application note and receipt of a signed copyright transfer agreement.
The application note must specifically reference by name one of the MDS Analytical Technologies products listed in the table above. The timeframe for application note finalization does not allow for projects that do not have results and data generated at the time of submission.
The application note should be based on an optimized protocol for performing the assay. The author(s) should have first-hand experience in performing the assay and should be in a position to know all experimental details related to the assay. The results should demonstrate successful use of the procedure to generate reproducible data for the intended application.
Accepted application notes will be published on the MDS AT website, as well as printed handouts disseminated at tradeshows, in company literature packets and/or for use in company presentations. Therefore, the methods and data should not be subject to copyrights or other rights, except those owned by the author(s), and to allow MDS AT to publicly disclose the application note.
Application note authors will be given full authorship credit in any MDS AT publication or use during a presentation of the method. Style, format, spelling, and grammar editing will be at MDS AT's discretion.
MDS AT has sole and final acceptance and refusal authority.
For questions regarding this program, please contact MDS AT at info@moldev.com and reference "Application Note Challenge" in the subject line.
Format and Preparation of Application Note
The application note should contain all details such as equipment, reagents and steps required to reproduce the results presented in the application note.
The application note must include the following sections:
Title: Should be brief and informative and should not include non-standard abbreviations. A short running title of no more than 50 characters (including spaces).
Authors: First name, last name, titles and affiliation.
Abstract: Very concise description of the content of the application note without any references and not to exceed 75 words.
Introduction: A description of the value and intended application of the protocol.
Reagents used: A list of all reagents, including vendor name and catalog number, needed for performing the experiment.
Equipment and Labware: All equipment and disposables required to perform the experiment, other than what is considered standard lab equipment (pipettes, tips, labcoat). If a specific brand equipment or disposable is required for performing the procedure, it should be detailed.
Special considerations (optional): Special reagent or sample handling requirements such as RNase free conditions for RNA work. Precautions and/or hazardous reagents (if any) should be listed here.
Protocol: The protocol should detail all the steps in the procedure in a step-wise manner as it is followed in the lab, with details such as pipetting volumes, incubation times and temperatures.
Tables and Figures: Tables and figures of data resulting from the direct use of the protocol for the intended application are to be numbered sequentially. Legends should follow each table or figure. Figure animations and images should be of print resolution and submitted as .tif files.
Results: Results section should be very concise and discuss the data shown in the tables and figures.
References: References should be listed at the end of the manuscript. They should be listed in the order in which they appear in the text. When cited in the text, references should be made in parenthesis as shown in the following example: (Brown & Botstein, 1999; Luzzi et al., 2003) Only papers that have been published or submitted should be cited in the reference list. The title of the article, the volume number and first and last pages should be cited. Journal titles should be abbreviated as shown in the example below.
Example of Reference Format:
Luzzi V., Mahadevappa M., Raja R., Warrington J. A., and Watson M. A. (2003). Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J Mol Diagn 5: 9-14.
For an example of a completed application note please download the following document:
MetaXpress-AcuityXpress-Transfluor-app.pdf
|